14Dec
Covid–19 coronavirus: global merger review (UPDATED)
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid 19. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). The table below reflects our understanding of the current effects on the merger review process in numerous jurisdictions around the world. It...
By:
Allen & Overy LLP
Related
Our Employee Benefits & Executive Compensation Group examines the numerous changes – mandatory and ...
Read More >
On May 21, 2020, the Securities and Exchange Commission (the “SEC”) amended the financial statemen...
Read More >
Yesterday, the IRS increased almost every major retirement plan limit as part of its annual cost of ...
Read More >
On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for ...
Read More >
Six months after the onset of the coronavirus pandemic, many merger and acquisition transactions rem...
Read More >
The last thing a party wants is a construction claim rising to the level of needing a mediator, judg...
Read More >